Article Information
PubMed
Print ISSN
Online ISSN
History
- Received October 28, 2015
- Accepted February 10, 2016
- Published online April 13, 2016.
Article Versions
- Earlier version (February 11, 2016 - 10:07).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright © 2016 by The American Society for Pharmacology and Experimental Therapeutics
Author Information
- Jessica Iegre,
- Martin A. Hayes,
- Richard A. Thompson,
- Lars Weidolf, and
- Emre M. Isin
- Cardiovascular and Metabolic Diseases, Innovative Medicines and Early Development Biotech Unit (J.I., M.A.H., L.W., E.M.I.) and Respiratory, Inflammation and Autoimmunity, Innovative Medicines and Early Development Biotech Unit (R.A.T.), AstraZeneca, Mölndal, Sweden
- Address correspondence to:
Emre M. Isin, Cardiovascular and Metabolic Diseases, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Pepparedsleden 1, SE-431 83 Mölndal, Sweden. E-mail: Emre.Isin{at}astrazeneca.com